Olanzapine Tablet, Film Coated
Product Images NDC 63187-453

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 63187-453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Olanzapineusp)

Chemical structure of olanzapine, showing its heterocyclic rings including a thieno[2,3-b][1,5]benzodiazepine core with a piperazine ring attached. The structure includes methyl and sulfur atoms as part of the molecular framework.*

FDA Label Image

63187-429-30 (Btl Lbl 10mg 30s)

Label for Olanzapine 10 mg film-coated tablets by Proficient Rx LP. The package contains 30 white, round, biconvex tablets engraved with "APO" on one side and "OLA" over "10" on the other. Manufactured by Apotex Inc., Toronto, Canada, with storage instructions at 20°-25°C (68°-77°F). Includes lot number and expiration date placeholders.*

FDA Label Image

63187-453-30 (Btl Lbl 2 5mg 30s)

Label for Olanzapine 2.5 mg film-coated tablets by Proficient Rx LP. The label states there are 30 tablets per package, each containing 2.5 mg of Olanzapine. Tablets are described as white, round, biconvex, with engravings "APO" on one side and "OLA" over "2.5" on the other. Manufactured by Apotex Inc., Toronto, Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.